About: Novo Nordisk

Health 30-01-2017

Drugmaker Novo Nordisk bets $145 mln on post-Brexit UK science

The world's largest producer of diabetes drugs has invested millions in a new research centre at the University of Oxford despite Brexit and a possible move of the European Medicines Agency from London.

Want to know what's going on in the EU Capitals daily? Subscribe now to our new 9am newsletter.